Unither Pharmaceuticals

Unither Pharmaceuticals is a global CDMO born in France, with 30+ years of aseptic expertise and innovation in drug development and manufacturing. Unither has a strong focus on ophthalmology, offering accessible and sustainable health solutions using Blow-Fill-Seal (BFS) technology for sterile unit-dose and multi-dose formats—with or without preservatives.​ ​ The development services support pharmaceutical and biotech companies from early stages through proof of concept, scale-up, and commercial production., bringing deep experience in biologics, small molecules, and novel formulations.​ ​
Unither actively invests in R&D to advance innovative, patient-centered molecules and delivery platforms. While ophthalmology remains their strategic focus, their sterile technologies also serve injectable, respiratory, nasal, and oral therapies.​ ​ With a global manufacturing network and flexible partnership models, they help clients deliver safe, effective, and compliant treatments that address patient needs and improve their lives.​ ​

"Together, let’s advance ophthalmic and sterile drug delivery.​ ​"